Invenomic Capital Management’s Xtrackers Harvest CSI 300 China A-Shares ETF ASHR Stock Holding History

Invenomic Capital Management’s Portfolio ASHR Stock Details ASHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Hold	7,388	–	–	0.02%	112
2026 Q1	$241K	Hold	7,388	–	–	0.01%	149
2025 Q4	$243K	Hold	7,388	–	–	0.01%	146
2025 Q3	$244K	Hold	7,388	–	–	0.01%	142
2025 Q2	$203K	Buy	+7,388	New	+$195K	0.01%	148

Other funds holding ASHR

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

CI Investments Inc Toronto, Ontario, Canada $31.2B AUM 40.61% 1-Year Est. Return

IPAM

ICICI Prudential Asset Management Mumbai, India $913M AUM 30.42% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invenomic Capital Management's ASHR Position: Q2 2026 in Review

Invenomic Capital Management held its Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) position steady in Q2 2026 at 7,388 shares worth $271K. The position accounts for 0.02% of the portfolio, ranked #112.

Invenomic Capital Management first reported a position in ASHR in Q2 2025 and has held it in 5 quarters since. 147 funds tracked by Wall St. Rank hold ASHR as of Q2 2026.

Invenomic Capital Management held 7,388 shares of Xtrackers Harvest CSI 300 China A-Shares ETF worth $271K as of Q2 2026.
Invenomic Capital Management left its Xtrackers Harvest CSI 300 China A-Shares ETF share count unchanged in Q2 2026.
Xtrackers Harvest CSI 300 China A-Shares ETF made up 0.02% of Invenomic Capital Management's portfolio in Q2 2026, its #112 holding.
Invenomic Capital Management first reported a position in Xtrackers Harvest CSI 300 China A-Shares ETF in Q2 2025 and has held it in 5 quarters since.
147 funds tracked by Wall St. Rank held Xtrackers Harvest CSI 300 China A-Shares ETF as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.